Inhibition of transforming growth factor beta signaling pathway promotes differentiation of human induced pluripotent stem cell-derived brain microvascular endothelial-like cells

Abstract Background The blood–brain barrier (BBB) plays an important role as a biological barrier by regulating molecular transport between circulating blood and the brain parenchyma. In drug development, the accurate evaluation of BBB permeability is essential to predict not only the efficacy but a...

Full description

Bibliographic Details
Main Authors: Misaki Yamashita, Hiromasa Aoki, Tadahiro Hashita, Takahiro Iwao, Tamihide Matsunaga
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Fluids and Barriers of the CNS
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12987-020-00197-1
id doaj-67a4ae874f4a412b8a6daa3d04a0df48
record_format Article
spelling doaj-67a4ae874f4a412b8a6daa3d04a0df482020-11-25T03:08:26ZengBMCFluids and Barriers of the CNS2045-81182020-05-0117111210.1186/s12987-020-00197-1Inhibition of transforming growth factor beta signaling pathway promotes differentiation of human induced pluripotent stem cell-derived brain microvascular endothelial-like cellsMisaki Yamashita0Hiromasa Aoki1Tadahiro Hashita2Takahiro Iwao3Tamihide Matsunaga4Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City UniversityDepartment of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City UniversityDepartment of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City UniversityDepartment of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City UniversityDepartment of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City UniversityAbstract Background The blood–brain barrier (BBB) plays an important role as a biological barrier by regulating molecular transport between circulating blood and the brain parenchyma. In drug development, the accurate evaluation of BBB permeability is essential to predict not only the efficacy but also the safety of drugs. Recently, brain microvascular endothelial-like cells derived from human induced pluripotent stem cells (iPSCs) have attracted much attention. However, the differentiation protocol has not been optimized, and the enhancement of iPSC-derived brain microvascular endothelial-like cells (iBMELCs) function is required to develop highly functional BBB models for pharmaceutical research. Thus, we attempted to improve the functions of differentiated iBMELCs and develop a versatile BBB model by modulating TGF-β signaling pathway without implementing complex techniques such as co-culture systems. Methods iPSCs were differentiated into iBMELCs, and TGF-β inhibitor was used in the late stage of differentiation. To investigate the effect of TGF-β on freezing–thawing, iBMELCs were frozen for 60–90 min or 1 month. The barrier integrity of iBMELCs was evaluated by transendothelial electrical resistance (TEER) values and permeability of Lucifer yellow. Characterization of iBMELCs was conducted by RT-qPCR, immunofluorescence analysis, vascular tube formation assay, and acetylated LDL uptake assay. Functions of efflux transporters were defined by intracellular accumulation of the substrates. Results When we added a TGF-β inhibitor during iBMELCs differentiation, expression of the vascular endothelial cell marker was increased and blood vessel-like structure formation was enhanced. Furthermore, TEER values were remarkably increased in three iPSC lines. Additionally, it was revealed that TGF-β pathway inhibition suppressed the damage caused by the freezing–thawing of iBMELCs. Conclusion We succeeded in significantly enhancing the function and endothelial characteristics of iBMELCs by adding a small molecular compound, a TGF-β inhibitor. Moreover, the iBMELCs could maintain high barrier function even after freezing–thawing. Taken together, these results suggest that TGF-β pathway inhibition may be useful for developing iPSC-derived in vitro BBB models for further pharmaceutical research.http://link.springer.com/article/10.1186/s12987-020-00197-1Blood–brain barrierCell differentiationEndothelial cellsInduced pluripotent stem cellsTransforming growth factor beta
collection DOAJ
language English
format Article
sources DOAJ
author Misaki Yamashita
Hiromasa Aoki
Tadahiro Hashita
Takahiro Iwao
Tamihide Matsunaga
spellingShingle Misaki Yamashita
Hiromasa Aoki
Tadahiro Hashita
Takahiro Iwao
Tamihide Matsunaga
Inhibition of transforming growth factor beta signaling pathway promotes differentiation of human induced pluripotent stem cell-derived brain microvascular endothelial-like cells
Fluids and Barriers of the CNS
Blood–brain barrier
Cell differentiation
Endothelial cells
Induced pluripotent stem cells
Transforming growth factor beta
author_facet Misaki Yamashita
Hiromasa Aoki
Tadahiro Hashita
Takahiro Iwao
Tamihide Matsunaga
author_sort Misaki Yamashita
title Inhibition of transforming growth factor beta signaling pathway promotes differentiation of human induced pluripotent stem cell-derived brain microvascular endothelial-like cells
title_short Inhibition of transforming growth factor beta signaling pathway promotes differentiation of human induced pluripotent stem cell-derived brain microvascular endothelial-like cells
title_full Inhibition of transforming growth factor beta signaling pathway promotes differentiation of human induced pluripotent stem cell-derived brain microvascular endothelial-like cells
title_fullStr Inhibition of transforming growth factor beta signaling pathway promotes differentiation of human induced pluripotent stem cell-derived brain microvascular endothelial-like cells
title_full_unstemmed Inhibition of transforming growth factor beta signaling pathway promotes differentiation of human induced pluripotent stem cell-derived brain microvascular endothelial-like cells
title_sort inhibition of transforming growth factor beta signaling pathway promotes differentiation of human induced pluripotent stem cell-derived brain microvascular endothelial-like cells
publisher BMC
series Fluids and Barriers of the CNS
issn 2045-8118
publishDate 2020-05-01
description Abstract Background The blood–brain barrier (BBB) plays an important role as a biological barrier by regulating molecular transport between circulating blood and the brain parenchyma. In drug development, the accurate evaluation of BBB permeability is essential to predict not only the efficacy but also the safety of drugs. Recently, brain microvascular endothelial-like cells derived from human induced pluripotent stem cells (iPSCs) have attracted much attention. However, the differentiation protocol has not been optimized, and the enhancement of iPSC-derived brain microvascular endothelial-like cells (iBMELCs) function is required to develop highly functional BBB models for pharmaceutical research. Thus, we attempted to improve the functions of differentiated iBMELCs and develop a versatile BBB model by modulating TGF-β signaling pathway without implementing complex techniques such as co-culture systems. Methods iPSCs were differentiated into iBMELCs, and TGF-β inhibitor was used in the late stage of differentiation. To investigate the effect of TGF-β on freezing–thawing, iBMELCs were frozen for 60–90 min or 1 month. The barrier integrity of iBMELCs was evaluated by transendothelial electrical resistance (TEER) values and permeability of Lucifer yellow. Characterization of iBMELCs was conducted by RT-qPCR, immunofluorescence analysis, vascular tube formation assay, and acetylated LDL uptake assay. Functions of efflux transporters were defined by intracellular accumulation of the substrates. Results When we added a TGF-β inhibitor during iBMELCs differentiation, expression of the vascular endothelial cell marker was increased and blood vessel-like structure formation was enhanced. Furthermore, TEER values were remarkably increased in three iPSC lines. Additionally, it was revealed that TGF-β pathway inhibition suppressed the damage caused by the freezing–thawing of iBMELCs. Conclusion We succeeded in significantly enhancing the function and endothelial characteristics of iBMELCs by adding a small molecular compound, a TGF-β inhibitor. Moreover, the iBMELCs could maintain high barrier function even after freezing–thawing. Taken together, these results suggest that TGF-β pathway inhibition may be useful for developing iPSC-derived in vitro BBB models for further pharmaceutical research.
topic Blood–brain barrier
Cell differentiation
Endothelial cells
Induced pluripotent stem cells
Transforming growth factor beta
url http://link.springer.com/article/10.1186/s12987-020-00197-1
work_keys_str_mv AT misakiyamashita inhibitionoftransforminggrowthfactorbetasignalingpathwaypromotesdifferentiationofhumaninducedpluripotentstemcellderivedbrainmicrovascularendotheliallikecells
AT hiromasaaoki inhibitionoftransforminggrowthfactorbetasignalingpathwaypromotesdifferentiationofhumaninducedpluripotentstemcellderivedbrainmicrovascularendotheliallikecells
AT tadahirohashita inhibitionoftransforminggrowthfactorbetasignalingpathwaypromotesdifferentiationofhumaninducedpluripotentstemcellderivedbrainmicrovascularendotheliallikecells
AT takahiroiwao inhibitionoftransforminggrowthfactorbetasignalingpathwaypromotesdifferentiationofhumaninducedpluripotentstemcellderivedbrainmicrovascularendotheliallikecells
AT tamihidematsunaga inhibitionoftransforminggrowthfactorbetasignalingpathwaypromotesdifferentiationofhumaninducedpluripotentstemcellderivedbrainmicrovascularendotheliallikecells
_version_ 1724666417645617152